ARTICLE Temporal trends in multiple sclerosis prevalence and incidence in a large population Dalia L. Rotstein, MD, MPH, Hong Chen, PhD, Andrew S. Wilton, MSc, Jeffrey C. Kwong, MD, Ruth Ann Marrie, MD, PhD, Peter Gozdyra, MA, Kristen M. Krysko, MD, Alexander Kopp, BA, Ray Copes, MD, MSc, and Karen Tu, MD, MSc Neurology ® 2018;0:1-7. doi:10.1212/WNL.0000000000005331 Correspondence Dr. Rotstein rotsteinda@smh.ca Abstract Objective We sought to better understand the reasons for increasing prevalence of multiple sclerosis (MS) by studying prevalence in relation to incidence, mortality rates, sex ratio, and geographic distribution of cases. Methods We identied MS cases from 1996 to 2013 in Ontario, Canada, by applying a validated algo- rithm to health administrative data. We calculated age- and sex-standardized prevalence and incidence rates for the province and by census division. Incidence and prevalence sex ratios for women to men were computed. Results The prevalence of MS increased by 69% from 1.57 (95% condence interval [CI]: 1.541.59) per 1,000 in 1996 (n = 12,155) to 2.65 (95% CI: 2.622.68) in 2013 (n = 28,192). Incidence remained relatively stable except for a spike in 2010, followed by a subsequent decline in 20112013, particularly among young people and men. Mortality decreased by 33% from 26.7 (95% CI: 23.530.3) per 1,000 to 18.0 (95% CI: 16.419.8) per 1,000. The incidence sex ratio was stable from 1996 to 2009, then declined in 2010, with partial rebound by 2013. MS prevalence and incidence showed no consistent association with latitude. Conclusion In this large, population-based MS cohort, we found stable incidence and increasing prevalence of MS; the latter largely reected declining mortality. A spike in incidence in 2010 among younger patients and men at a time of widespread media coverage of MS suggests that these groups may be vulnerable to delayed diagnosis. We did not nd a latitudinal gradient; however, most Ontarians live between the 42nd and 46th parallels, reducing our ability to detect an eect of latitude. From the Division of Neurology, Department of Medicine (D.L.R., K.M.K.), Dalla Lana School of Public Health (H.C., R.C.), and Department of Family and Community Medicine (J.C.K., K.T.), University of Toronto; St. Michaels Hospital (D.L.R., P.G.), Toronto; Institute for Clinical Evaluative Sciences (D.L.R., H.C., A.S.W., J.C.K., A.K.), Toronto; Public Health Ontario (H.C., R.C.), Toronto; Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba; and Toronto Western Family Health Team (K.T.), University Health Network, Toronto, Canada. Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article Copyright © 2018 American Academy of Neurology 1 Copyright ª 2018 American Academy of Neurology. Unauthorized reproduction of this article is prohibited. Published Ahead of Print on March 16, 2018 as 10.1212/WNL.0000000000005331